| Literature DB >> 25518849 |
Arjan P Palstra, Mireia Rovira, David Rizo-Roca, Joan Ramon Torrella, Herman P Spaink, Josep V Planas1.
Abstract
BACKGROUND: The adult skeletal muscle is a plastic tissue with a remarkable ability to adapt to different levels of activity by altering its excitability, its contractile and metabolic phenotype and its mass. We previously reported on the potential of adult zebrafish as a tractable experimental model for exercise physiology, established its optimal swimming speed and showed that swimming-induced contractile activity potentiated somatic growth. Given that the underlying exercise-induced transcriptional mechanisms regulating muscle mass in vertebrates are not fully understood, here we investigated the cellular and molecular adaptive mechanisms taking place in fast skeletal muscle of adult zebrafish in response to swimming.Entities:
Mesh:
Year: 2014 PMID: 25518849 PMCID: PMC4378002 DOI: 10.1186/1471-2164-15-1136
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Morphometrical fibre parameters in fast muscle of exercised and non-exercised adult zebrafish. A: Image of the swim tunnels used for exercise training. Front tunnel: exercised zebrafish; back tunnel: non-exercised zebrafish. B-D: Images of zebrafish cross-sectional white muscle. Images correspond to representative serial transverse secions stained (B) for succinate dehydrogenase for the identification of fast, intermediate (pink) and slow muscle fibres; (C and D) for ATPase for capillary demonstration (arrows) and FCSA and FPER measures (white drawing) from a non-exercised (C) and an exercised (D) adult zebrafish. Bar represents 50 μm. Morphometric fibre parameters measured in non-exercised and exercised zebrafish were: FCSA, fibre cross-sectional area (μm2) (E); FPER, fibre perimeter (μm) (F); FD, fibre density (fibres/mm2) (G); SF, shape factor (H). Statistical significance values between non-exercised and exercised zebrafish: *P < 0.05. Values are mean ± SEM from a sample size of n = 8 for each condition. I-J: Fibre cross-sectional area histograms from fast muscle of exercised (I) and non-exercised (J) adult zebrafish. In K, the two overlapped curves are shown. Muscle fibre areas were grouped in intervals of 200 μm2 and the data correspond to mean ± SEM frequency of six animals. Curves represent a log-normal regression of four parameters. Regression parameters are shown in Additional file 1. See Methods for details.
Figure 2Morphometrical capillarity parameters in fast muscle of exercised and non-exercised adult zebrafish. Parameters measured were: CD, capillary density (capillaries/mm2) (A); NCF, number of capillaries in contact with each fibre (B); CCA, relationship between NCF and the FCSA (NCF · 103/FCSA) (C); CCP, relationship between NCF and the FPER (NCF · 102/FPER) (D); C/F, capillary-to-fibre ratio (CD/FD) (E) and MDD, maximal diffusion distance between the capillary and the centre of the fibre (F). Statistical significance values between non-exercised and exercised zebrafish: *P < 0.05, **P < 0.01, ***P < 0.001. Values are mean ± SEM from a sample size of n = 8 for each condition.
Functional annotation analysis based on GO terms in zebrafish fast muscle in response to swimming (DAVID)
| GO Term | Count | P-value | |
|---|---|---|---|
| GO:0014706 | Striated muscle tissue development | 41 | 0,0014644 |
| GO:0051146 | Striated muscle cell differentiation | 31 | 0,0042799 |
| GO:0030239 | Myofibril assembly | 10 | 0,0227268 |
| GO:0031032 | Actomyosin structure organization | 14 | 0,0028624 |
| GO:0032956 | Regulation of actin cytoskeleton organization | 28 | 0,0318891 |
| GO:0040007 | Growth | 65 | 1,72E-05 |
| GO:0045926 | Negative regulation of growth | 36 | 0,0074826 |
| GO:0000278 | Mitotic cell cycle | 124 | 8,01E-08 |
| GO:0051726 | Regulation of cell cycle | 92 | 0,0053137 |
| GO:0006915 | Apoptosis | 161 | 0,0014411 |
| GO:0043065 | Positive regulation of apoptosis | 110 | 0,0295542 |
| GO:0006457 | Protein folding | 60 | 1,67E-04 |
| GO:0030162 | Regulation of proteolysis | 19 | 0,0245616 |
| GO:0006468 | Protein amino acid phosphorylation | 173 | 0,0038954 |
| GO:0006511 | Ubiquitin-dependent protein catabolic process | 84 | 2,55E-06 |
| GO:0006979 | Response to oxidative stress | 46 | 0,0414755 |
| GO:0080135 | Regulation of cellular response to stress | 31 | 0,0418028 |
| GO:0045454 | Cell redox homeostasis | 21 | 0,0378637 |
| GO:0015980 | Energy derivation by oxidation of organic compounds | 51 | 1,68E-04 |
| GO:0022900 | Electron transport chain | 41 | 5,67E-04 |
| GO:0006754 | ATP biosynthetic process | 32 | 0,0025614 |
| GO:0006119 | Oxidative phosphorylation | 44 | 5,45E-07 |
| GO:0044262 | Cellular carbohydrate metabolic process | 111 | 6,80E-04 |
| GO:0006096 | Glycolysis | 21 | 9,35E-04 |
| GO:0044255 | Cellular lipid metabolic process | 157 | 4,84E-06 |
| GO:0006635 | Fatty acid beta-oxidation | 15 | 7,99E-04 |
| GO:0006631 | Fatty acid metabolic process | 75 | 2,13E-07 |
| GO:0006633 | Fatty acid biosynthetic process | 30 | 0,0013958 |
| GO:0006520 | Cellular amino acid metabolic process | 71 | 5,16E-04 |
| GO:0042180 | Cellular ketone metabolic process | 190 | 1,95E-11 |
| GO:0001568 | Blood vessel development | 78 | 1,68E-04 |
| GO:0048514 | Blood vessel morphogenesis | 68 | 3,13E-04 |
| GO:0001570 | Vasculogenesis | 16 | 0,0194009 |
| GO:0045449 | Regulation of transcription | 593 | 0,0425425 |
| GO:0043408 | Regulation of MAPKKK cascade | 35 | 0,011466 |
| GO:0051101 | Regulation of DNA binding | 42 | 0,0010788 |
| GO:0007243 | Protein kinase cascade | 95 | 0,0387284 |
| GO:0030509 | BMP signaling pathway | 17 | 0,0170619 |
| GO:0016055 | Wnt receptor signaling pathway | 53 | 2,84E-06 |
Selected differentially expressed genes in fast muscle of exercised zebrafish that participate in the contractile activation of skeletal muscle fibers
| Gene name gene description | FC | Gene name gene description | FC | ||
|---|---|---|---|---|---|
| Muscle contraction | Muscle growth and development | ||||
|
| Calpain 8 |
|
| Fibroblast growth factor 20 |
|
|
| Actinin, alpha 4 |
|
| Histone deacetylase 6 |
|
|
| Myosin, heavy chain 11, smooth muscle |
|
| Fibroblast growth factor 18 |
|
|
| Ca/calmodulin-dependent protein kinase II inhibitor 2 |
|
| Wingless-type MMTV integration site, 10A |
|
|
| Parvalbumin |
|
| Paired box 3 |
|
|
| Troponin I type 2 (skeletal, fast) |
|
| Transforming growth factor, beta 2 |
|
|
| Calpain 3, (p94) |
|
| Noggin |
|
|
| Nuclear factor of activated T-cells, calcineurin-dep. 4 |
|
| Estrogen-related receptor alpha |
|
|
| Calpain 2, (m/II) large subunit |
|
| Wingless-type MMTV integration site, 7A |
|
|
| Tropomodulin 4 (muscle) |
|
| Myostatin |
|
|
| Nuclear factor of activated T-cells, , calcineurin-dep. 1 |
|
| Forkhead box A1 |
|
|
| Capping protein (actin filament) muscle Z-line, beta |
|
| Fibroblast growth factor receptor 2 |
|
|
| Calsequestrin 1 (fast-twitch, skeletal muscle) |
|
| Sonic hedgehog |
|
|
| Myosin, light chain 2, regulatory, cardiac, slow |
|
| Frizzled family receptor 2 |
|
|
| Protein phosphatase 3, catalytic subunit, gamma |
|
| Phosphatidylinositol-4-p- 3-kinase c2b |
|
|
| Calpain 5 |
|
| Fibroblast growth factor 13 |
|
|
| Titin |
|
| Mitogen-activated protein kinase 1 |
|
|
| Protein phosphatase 3, catalytic subunit, alpha isozyme |
|
| Frizzled family receptor 10 |
|
|
| Myosin light chain, phosphorylatable, fast skel. muscle |
|
| Indian hedgehog |
|
|
| Myosin binding protein H |
|
| Frizzled family receptor 8 |
|
|
| Calpain 10 |
|
| Estrogen-related receptor beta |
|
|
| Calcium channel, voltage-dependent, L type, alpha 1S |
|
| Bone morphogenetic protein receptor, IA |
|
|
| Calcium/calmodulin-dependent protein kinase II alpha |
|
| Nerve growth factor (beta polypeptide) |
|
|
| Calcium/calmodulin-dependent protein kinase II delta |
|
| Insulin-like growth factor 1 receptor |
|
|
| Nuclear factor of activated T-cells, calcineurin-dep. 3 |
|
| Bone morphogenetic protein 1 |
|
|
| Actin, alpha 2, smooth muscle, aorta |
|
| Dishevelled, dsh homolog 1 (Drosophila) |
|
|
| Myosin light chain kinase |
|
| SMAD family member 2 |
|
|
| Tropomyosin 4 |
|
| Bone morphogenetic protein 4 |
|
|
| Myosin, light chain 9, regulatory |
|
| Insulin-like growth factor binding protein 7 |
|
|
| Ryanodine receptor 1 (skeletal) |
|
| Estrogen-related receptor gamma |
|
|
| Tropomyosin 1 (alpha) |
|
| Bone morphogenetic protein receptor, IB |
|
|
| ATPase, Ca transporting, cardiac muscle, fast twitch 1 |
|
| v-erb-b2 erythroblastic leukemia. 2 |
|
|
| Actin, alpha, cardiac muscle 1 |
|
| Mitogen-activated protein kinase 13 |
|
|
| Calcium channel, voltage-dependent, gamma subunit 1 |
|
| Follistatin |
|
|
| Myosin, light chain 12B, regulatory |
|
| Mitogen-activated protein kinase 8 |
|
|
| S100 calcium binding protein A4 |
|
| SMAD family member 6 |
|
|
| Calmodulin 1 (phosphorylase kinase, delta) |
|
| Fibroblast growth factor receptor 1 |
|
|
| Actin, gamma 2, smooth muscle, enteric |
|
| Insulin receptor substrate 2 |
|
|
| Troponin T type 3 (skeletal, fast) |
|
| Runt-related transcription factor 2 |
|
|
|
| Insulin-like growth factor binding protein 1 |
| ||
|
| Ankyrin 2, neuronal |
|
| Insulin receptor substrate 1 |
|
|
| Plectin |
|
| Activin A receptor, type IIB |
|
|
| Myozenin 1 |
|
| Transforming growth factor, beta 1 |
|
|
| Myozenin 2 |
|
| Myocyte enhancer factor 2D |
|
|
| Dystroglycan 1 (dystrophin-associated glycoprotein 1) |
|
| Histone deacetylase 4 |
|
|
| Integrin, beta 4 |
|
| Insulin-like growth factor binding protein 3 |
|
|
| Integrin, alpha 2b |
|
| Myocyte enhancer factor 2A |
|
|
| Dystrophin |
|
| Insulin-like growth factor 2 |
|
|
| Filamin A interacting protein 1 |
|
| Phosphatase and tensin homolog |
|
|
| Syntrophin, beta 1 (dystrophin-associated protein A1) |
|
| Myocyte enhancer factor 2C |
|
|
| Vimentin |
|
| Epidermal growth factor receptor |
|
|
| Lamin A/C |
|
| Inhibitor of DNA binding 3 |
|
|
| Dystrobrevin binding protein 1 |
|
| Serum response factor |
|
|
| Filamin C, gamma |
|
| Mitogen-activated protein kinase 14 |
|
|
|
| ||||
|
| Acetylcholinesterase |
|
| Collagen, type VIII, alpha 2 |
|
|
| Vesicle-associated membrane prot. 1 (synaptobrevin1) |
|
| Laminin, gamma 3 |
|
|
| Cholinergic receptor, muscarinic 2 |
|
| Collagen, type XVI, alpha 1 |
|
|
| Synaptosomal-associated protein, 25kDa |
|
| Collagen, type I, alpha 2 |
|
|
| Sodium channel, voltage-gated, type IV, beta subunit |
|
| Biglycan |
|
|
| Synapsin II |
|
| Lysyl oxidase-like 2 |
|
|
| Synaptotagmin I |
|
| Matrix metallopeptidase 14 |
|
|
| Regulating synaptic membrane exocytosis 2 |
|
| Tenascin C |
|
|
| Sodium channel modifier 1 |
|
| Matrix metallopeptidase 10 (stromelysin 2) |
|
|
| Synaptotagmin binding, cytoplasmic RNA interact. pro. |
|
| Syndecan binding protein (syntenin) |
|
Data are shown as fold change (FC).
Functional categories are indicated in bold.
Selected differentially expressed genes in fast muscle of exercised adult zebrafish that participate in angiogenesis, immune-related processess and metabolism
| Gene name gene description | FC | Gene name gene description | FC | ||
|---|---|---|---|---|---|
| Angiogenesis | Energy metabolism | ||||
|
| Kruppel-like factor 2 (lung) |
|
| Carnitine palmitoyltransferase 1A (liver) |
|
|
| Roundabout, axon guidance receptor, homolog 2 (Drosophila) |
|
| Phosphofructokinase, muscle |
|
|
| Angiopoietin 2 |
|
| Protein kinase, AMP-activated, alpha 1 cat. |
|
|
| Angiopoietin-like 3 |
|
| ELOVL fatty acid elongase 4 |
|
|
| Ephrin-A3 |
|
| Protein kinase, AMP-activated, gamma 1 catalytic subunit |
|
|
| GATA binding protein 1 (globin transcription factor 1) |
|
| Acyl-CoA dehydrogenase, long chain |
|
|
| EPH receptor A4 |
|
| Peroxisome proliferator-activated receptor d |
|
|
| Neuropilin 1 |
|
| Aldolase A, fructose-bisphosphate |
|
|
| Matrix metallopeptidase 14 (membrane-inserted) |
|
| Malonyl CoA:ACP acyltransferase (mitochondrial) |
|
|
| Nitric oxide synthase 1 (neuronal) |
|
| Solute carrier family 27 (fatty acid transporter), member 2 |
|
|
| Notch 1 |
|
| Protein kinase, AMP-activated, beta 1 non-catalytic subunit |
|
|
| Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
|
| Myoglobin |
|
|
| Slit homolog 3 (Drosophila) |
|
| Cytochrome c oxidase subunit VIIc |
|
|
| Angiomotin |
|
| Peroxisome proliferator-activated receptor alpha |
|
|
| Hairy/enhancer-of-split related with YRPW motif 2 |
|
| Transcription factor B2, mitochondrial |
|
|
| Tumor protein p63 |
|
| Fructose-1,6-bisphosphatase 1 |
|
|
| Matrix metallopeptidase 10 (stromelysin 2) |
|
| Glucose-6-phosphatase, catalytic subunit |
|
|
| Sphingosine-1-phosphate receptor 1 |
|
| Pyruvate dehydrogenase (lipoamide) alpha 1 |
|
|
| EPH receptor B4 |
|
| Creatine kinase, muscle |
|
|
| Nuclear receptor subfamily 2, group F, member 2 |
|
| Fumarate hydratase |
|
|
| Ephrin-B3 |
|
| Oxoglutarate hydrogenase (lipoamide) |
|
|
| Hypoxia inducible factor 3, alpha subunit |
|
| Glyceraldehyde-3-phosphate dehydrogenase |
|
|
| EPH receptor A7 |
|
| Alcohol dehydrogenase 5 (class III) |
|
|
| Angiopoietin-like 2 |
|
| Cytochrome c oxidase subunit Va |
|
|
| Nitric oxide synthase 2, inducible |
|
| Phosphoglycerate kinase 1 |
|
|
| CDC42 effector protein (Rho GTPase binding) 2 |
|
| Fatty acid desaturase 6 |
|
|
| Ephrin-A2 |
|
| Malate dehydrogenase 2, NAD (mitochondrial) |
|
|
| Nuclear receptor subfamily 2, group F, member 1 |
|
| Cytochrome c oxidase subunit VIa polypeptide 2 |
|
|
| Jagged 1 |
|
| NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa |
|
|
| Slit homolog 2 (Drosophila) |
|
| Fatty acid binding protein 3, muscle and heart |
|
|
| Hairy/enhancer-of-split related with YRPW motif 1 |
|
| Solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
| Hypoxia inducible factor 1, alpha subunit inhibitor |
|
| ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d |
|
|
| Forkhead box C1 |
|
| Uncoupling protein 3 (mitochondrial ) |
|
|
| Ephrin-B2 |
|
| Carnitine palmitoyltransferase 2 |
|
|
| Jagged 2 |
|
| NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa |
|
|
| Vascular endothelial growth factor C |
|
| Creatine kinase, mitochondrial 2 (sarcomeric) |
|
|
| Delta-like 1 (Drosophila) |
|
| Malate dehydrogenase 1, NAD (soluble) |
|
|
| Ras-related C3 botulinum toxin substrate 1 |
|
| Succinate dehydrogenase complex, subunit A, |
|
|
| Rho-associated, coiled-coil containing protein kinase 2 |
|
| ATP synthase F0 subunit 6 |
|
|
| Notch 2 |
|
| Acetyl-CoA carboxylase beta |
|
|
| Cell division cycle 42 |
|
| Uncoupling protein 2 (mitochondrial) |
|
|
| Angiogenic factor with G patch and FHA domains 1 |
|
| ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
|
|
| Enolase 1, (alpha) |
| ||
|
| TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
|
| Cytochrome c oxidase subunit IV isoform 1 |
|
|
| Interleukin 17D |
|
| Cytochrome c oxidase subunit VIIa polypeptide 2 like |
|
|
| Prostaglandin-endoperoxide synthase 1 |
|
| ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 |
|
|
| Interleukin-1 receptor-associated kinase 1 BP 1 |
|
| Nuclear respiratory factor 1 |
|
|
| Interferon regulatory factor 3 |
|
| Lactate dehydrogenase B |
|
|
| Interleukin 20 receptor, alpha |
|
| Adiponectin receptor 2 |
|
|
| Interleukin 12B |
|
| Lipoprotein lipase |
|
|
| Interleukin 11 receptor, alpha |
|
| Eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa |
|
|
| Prostaglandin reductase 1 |
|
| Glucose-6-phosphate isomerase |
|
|
| Prostaglandin D2 synthase 21kDa (brain) |
|
| NADH dehydrogenase (ubiquinone) complex I, assembly factor 4 |
|
|
| Prostaglandin I2 (prostacyclin) synthase |
|
| Aldolase C, fructose-bisphosphate |
|
|
| Interleukin 13 receptor, alpha 2 |
|
| Pyruvate kinase, muscle |
|
|
| Interleukin 20 |
|
| Hexokinase 2 |
|
|
| Tumor necrosis factor receptor superfamily, member 19 |
|
| ||
|
| NFKB repressing factor |
|
| Pyruvate dehydrogenase kinase, isozyme 2 |
|
|
| Interleukin 17 receptor D |
|
| F-box protein 32 |
|
|
| Macrophage stimulating 1 (hepatocyte growth factor-like) |
|
| Pyruvate dehydrogenase kinase, isozyme 1 |
|
|
| Macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
| Forkhead box O3 |
|
|
| Interleukin enhancer binding factor 3, 90kDa |
|
| Tripartite motif containing 63, E3 ubiquitin protein ligase |
|
|
| Prostaglandin E synthase 3 (cytosolic) |
|
| Ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
|
|
| Interleukin 21 receptor |
|
| Eukaryotic translation initiation factor 4E |
|
|
| Interleukin-1 receptor-associated kinase 4 |
|
| Eukaryotic translation initiation factor 4E binding protein 1 |
|
Data are shown as fold change (FC).
Functional categories are indicated in bold.
Significantly over-represented putative canonical pathways in fast muscle of exercised zebrafish
| Ingenuity canonical pathways | p-Value | Ratio |
|---|---|---|
| Integrin Signaling | 3.28E-16 | 94/208 |
| Protein Ubiquitination Pathway | 3.62E-12 | 103/268 |
| Wnt/β-catenin Signaling | 5.57E-11 | 75/175 |
| mTOR Signaling | 6.06E-06 | 68/211 |
| TGF-β Signaling | 7.22E-06 | 36/89 |
| Ephrin B Signaling | 2.46E-05 | 32/82 |
| Actin Cytoskeleton Signaling | 3.04E-05 | 72/239 |
| IGF-1 Signaling | 6.53E-05 | 38/105 |
| Glycolysis | 1.01E-04 | 14/41 |
| VEGF Signaling | 1.03E-04 | 36/104 |
| AMPK Signaling | 4.67E-04 | 46/169 |
| Calcium Signaling | 6.03E-04 | 58/213 |
| Insulin Receptor Signaling | 1.22E-03 | 44/142 |
| FGF Signaling | 1.53E-03 | 31/92 |
| Chemokine Signaling | 1.72E-03 | 26/73 |
| PI3K/AKT Signaling | 1.75E-03 | 41/144 |
| Fatty Acid β-oxidation | 1.99E-03 | 14/45 |
| Hypoxia Signaling in the Cardiovascular System | 4.35E-03 | 24/67 |
| PDGF Signaling | 4.63E-03 | 27/85 |
| HIF1α Signaling | 9.07E-03 | 33/108 |
| Notch Signaling | 9.60E-03 | 15/43 |
| Angiopoietin Signaling | 3.00E-02 | 21/74 |
The associated p-value (Fisher’s exact test P < 0.05) and the ratio of the number of differentially expressed genes in fast muscle of exercised zebrafish over the total number of genes in each particular pathway in the Ingenuity Knowledge Base. Canonical pathway names are from Ingenuity Systems.
Figure 3IPA-based network generated from molecules involved in muscle development and myogenesis that are differentially expressed in fast muscle of exercised adult zebrafish. The shapes of the genes correlate with the functional classification symbolised in the legend. Arrows represent the direct relationship between molecules. Color intensity correlates to transcription value, calculated as log2ratio (exercised/non-exercised); green represents molecules with repressed transcription (negative log2ratio); red represents molecules with enhanced transcription (positive log2ratio).
Figure 4IPA-based network generated from molecules involved in angiogenesis that are differentially expressed in fast muscle of exercised adult zebrafish. The shapes of the genes correlate with the functional classification symbolised in the legend. Arrows represent the direct relationship between molecules. Color intensity correlates to transcription value, calculated as log2ratio (exercised/non-exercised); green represents molecules with repressed transcription (negative log2ratio); red represents molecules with enhanced transcription (positive log2ratio).